Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Genetic Disease

Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Last 

Arizona

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Retinal Consultants of Arizona
Gilbert Arizona 85296

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Retinal Consultants of Arizona
Mesa Arizona 85210

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Retina Consultants of Arizona
Peoria Arizona 85381

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Retinal Consultants of Arizona
Peoria Arizona 85381

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

View More »

Phoenix Arizona 85014

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Retina Consultants of Arizona
Phoenix Arizona 85014

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Associated Retina Consultants
Phoenix Arizona 85020

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Retinal Consultants of Arizona
Phoenix Arizona 85014

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona

A Phase 2 clinical study for patients with Macular Degeneration

Novartis Investigative Site
Phoenix Arizona 85020

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Novartis Investigative Site
Phoenix Arizona 85014

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Retina Centers, P.C.
Tucson Arizona 85704

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Tucson Arizona 85704

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Tucson Arizona 85710

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Novartis Investigative Site
Tucson Arizona 85704-5614

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

California

California Retina Consultants
Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

Bakersfield California

A clinical trial seeking patients for a research study for the treatment of Age-Related Macular Degeneration

Bakersfield California 93309

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Beverly Hills California

A clinical trial seeking patients for a research study for the treatment of Age-Related Macular Degeneration

View More »

Beverly Hills California 90211

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Retina-Vitreous Associates Medical Group
Beverly Hills California 90211

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Novartis Investigative Site
Beverly Hills California 90211

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Retina Vitreous Associates Medical Group
Beverly Hills California 90211

Patients are needed to participate in a clinical research study of X-82 oral and ranibizumab (Lucentis) to evaluate Exudative Macular Degeneration

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Retinal Diagnostic Center
Campbell California 95008

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Fresno California 93720

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Specialty Eye Care Medical Center
Glendale California 91203

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Shiley Eye Center, UCSD
La Jolla California 92093

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

La Jolla California 92093

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Retina Associates of Orange County
Laguna Hills California 92653

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Loma Linda California 92354

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Jules Stein Eye Institute/UCLA
Los Angeles California 90095

A clinical research study of Microplasmin and Placebo control for the treatment of Macular Degeneration

Jules Stein Eye Institute, UCLA School of Medicine
Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Dry Age Related Macular Degeneration

Los Angeles California 90095

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Jules Stein Eye Institute, UCLA School of Medicine
Los Angeles California 90095

A clinical trial to evaluate treatments using MA09-hRPE Cellular therapy for patients with Stargardt's Macular Dystrophy

Marietta Eye Clinic
Marietta California 30060

A clinical trial to evaluate treatments using pegaptanib sodium injection for patients with Age-Related Macular Degeneration, Retinal Vein Occlusion or Diabetic Macular Edema

Northern California Retina Vitreous Associates
Mountain View California 94040

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Mountain View California 94040

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Northern California Retina Vitreous Associates
Mountain View California 94040

Patients are needed to participate in a clinical research study evaluating Ranibizumab for the treatment of Recalcitrant Wet Age-related Macular Degeneration

Sagar Kenyon American Eye Institute
New Albany California 47150

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Palm Desert California 92211

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Novartis Investigative Site
Pasadena California 91105-3153

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Sacramento California 95819

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Sacramento California 95841

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Retinal Consultants Medical Group, Inc.
Sacramento California 95819

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Sacramento California 95819

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Novartis Investigative Site
Sacramento California 95841

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Last